Second Malignancies in Total Therapy 3 Trials for Newly Diagnosed Multiple Myeloma: Influence of Lenalidomide Versus Thalidomide in Maintenance Phases

被引：0
|
作者：
Usmani, Saad [1 ]
Sexton, Rachael [2 ]
Hoering, Antje [2 ]
Heuck, Christoph [1 ]
Nair, Bijay [1 ]
Waheed, Sarah [1 ]
Alsayed, Yazan [1 ]
Petty, Nathan M. [1 ]
Crowley, John [2 ]
Barlogie, Bart [1 ]
机构：
[1] Univ Arkansas Med Sci, Myeloma Inst Res & Therapy, Little Rock, AR 72205 USA
[2] Canc Res & Biostat, Res & Biostat, Seattle, WA USA
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：375 / 375
页数：1
相关论文
共 50 条
  • [21] Initial therapy with thalidomide/dexamethasone versus lenalidimide/dexamethasone in newly diagnosed multiple myeloma: A retrospective analysis of two phase II trials
    Nowakowski, G. S.
    Lacy, M. Q.
    Gertz, M. A.
    Dispenzieri, A.
    Dingli, D.
    Greipp, P. R.
    Kumar, S.
    Geyer, S.
    Fonseca, R.
    Vivek, R.
    Hayman, S.
    Lust, J. A.
    Kyle, R. A.
    Witzig, T. E.
    Rajkumar, S. V.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 179 - 179
  • [22] Maintenance therapy in newly diagnosed multiple myeloma: current recommendations
    Brioli, Annamaria
    Tacchetti, Paola
    Zamagni, Elena
    Cavo, Michele
    EXPERT REVIEW OF ANTICANCER THERAPY, 2014, 14 (05) : 581 - 594
  • [23] The Role of Maintenance Therapy in the Treatment of Newly Diagnosed Multiple Myeloma
    Gahvari, Zhubin
    Callander, Natalie
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S53 - S56
  • [24] Daratumumab with lenalidomide as maintenance after transplant in newly diagnosed multiple myeloma: the AURIGA study
    Badros, Ashraf
    Foster, Laahn
    Anderson Jr, Larry D.
    Chaulagain, Chakra P.
    Pettijohn, Erin
    Cowan, Andrew J.
    Costello, Caitlin
    Larson, Sarah
    Sborov, Douglas W.
    Shain, Kenneth H.
    Silbermann, Rebecca
    Shah, Nina
    Chung, Alfred
    Krevvata, Maria
    Pei, Huiling
    Patel, Sharmila
    Khare, Vipin
    Cortoos, Annelore
    Carson, Robin
    Lin, Thomas S.
    Voorhees, Peter
    BLOOD, 2025, 145 (03) : 300 - 310
  • [25] Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial
    Jackson, Graham H.
    Davies, Faith E.
    Pawlyn, Charlotte
    Cairns, David A.
    Striha, Alina
    Collett, Corinne
    Hockaday, Anna
    Jones, John R.
    Kishore, Bhuvan
    Garg, Mamta
    Williams, Cathy D.
    Karunanithi, Kamaraj
    Lindsay, Jindriska
    Jenner, Matthew W.
    Cook, Gordon
    Russell, Nigel H.
    Kaiser, Martin F.
    Drayson, Mark T.
    Owen, Roger G.
    Gregory, Walter M.
    Morgan, Gareth J.
    LANCET ONCOLOGY, 2019, 20 (01): : 57 - 73
  • [26] Thalidomide added to standard therapy improves survival in newly diagnosed multiple myeloma
    不详
    ONCOLOGY-NEW YORK, 2006, 20 (12): : 1486 - 1486
  • [27] Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma
    Richardson, Paul G.
    Weller, Edie
    Lonial, Sagar
    Jakubowiak, Andrzej J.
    Jagannath, Sundar
    Raje, Noopur S.
    Avigan, David E.
    Xie, Wanling
    Ghobrial, Irene M.
    Schlossman, Robert L.
    Mazumder, Amitabha
    Munshi, Nikhil C.
    Vesole, David H.
    Joyce, Robin
    Kaufman, Jonathan L.
    Doss, Deborah
    Warren, Diane L.
    Lunde, Laura E.
    Kaster, Sarah
    DeLaney, Carol
    Hideshima, Teru
    Mitsiades, Constantine S.
    Knight, Robert
    Esseltine, Dixie-Lee
    Anderson, Kenneth C.
    BLOOD, 2010, 116 (05) : 679 - 686
  • [28] Front-line lenalidomide therapy in patients with newly diagnosed multiple myeloma
    Cejalvo, Maria J.
    de la Rubia, Javier
    FUTURE ONCOLOGY, 2015, 11 (11) : 1643 - 1658
  • [29] Thalidomide plus dexamethasone as primary therapy for newly diagnosed patients with multiple myeloma
    Meletios A Dimopoulos
    Efstathios Kastritis
    Nature Clinical Practice Oncology, 2008, 5 : 690 - 691
  • [30] Thalidomide plus dexamethasone as primary therapy for newly diagnosed patients with multiple myeloma
    Dimopoulos, Meletios A.
    Kastritis, Efstathios
    NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (12): : 690 - 691
12345